Suppr超能文献

老年人心血管疾病预后改善

Improved Cardiovascular Disease Outcomes in Older Adults.

作者信息

Forman Daniel E, Alexander Karen, Brindis Ralph G, Curtis Anne B, Maurer Mathew, Rich Michael W, Sperling Laurence, Wenger Nanette K

机构信息

Geriatric Cardiology Section, University of Pittsburgh Medical Center, Geriatric Research, Education, and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.

出版信息

F1000Res. 2016 Jan 28;5. doi: 10.12688/f1000research.7088.1. eCollection 2016.

Abstract

Longevity is increasing and the population of older adults is growing. The biology of aging is conducive to cardiovascular disease (CVD), such that prevalence of coronary artery disease, heart failure, valvular heart disease, arrhythmia and other disorders are increasing as more adults survive into old age.  Furthermore, CVD in older adults is distinctive, with management issues predictably complicated by multimorbidity, polypharmacy, frailty and other complexities of care that increase management risks (e.g., bleeding, falls, and rehospitalization) and uncertainty of outcomes.  In this review, state-of-the-art advances in heart failure, acute coronary syndromes, transcatheter aortic valve replacement, atrial fibrillation, amyloidosis, and CVD prevention are discussed.  Conceptual benefits of treatments are considered in relation to the challenges and ambiguities inherent in their application to older patients.

摘要

寿命在延长,老年人的人口数量在增长。衰老生物学易引发心血管疾病(CVD),随着越来越多的成年人步入老年,冠状动脉疾病、心力衰竭、心脏瓣膜病、心律失常及其他疾病的患病率也在上升。此外,老年人的心血管疾病具有独特性,管理问题因多重疾病、多种药物治疗、身体虚弱及其他护理复杂性而变得复杂,这些因素增加了管理风险(如出血、跌倒和再次住院)以及结果的不确定性。在本综述中,将讨论心力衰竭、急性冠状动脉综合征、经导管主动脉瓣置换术、心房颤动、淀粉样变性和心血管疾病预防方面的最新进展。会结合治疗应用于老年患者时所固有的挑战和不确定性来考虑治疗的理论益处。

相似文献

1
Improved Cardiovascular Disease Outcomes in Older Adults.
F1000Res. 2016 Jan 28;5. doi: 10.12688/f1000research.7088.1. eCollection 2016.
2
Cardiac Rehabilitation in Older Adults.
Can J Cardiol. 2016 Sep;32(9):1088-96. doi: 10.1016/j.cjca.2016.03.003. Epub 2016 Mar 10.
5
Cardiac rehabilitation for older adults: current evidence and future potential.
Expert Rev Cardiovasc Ther. 2022 Jan;20(1):13-34. doi: 10.1080/14779072.2022.2035722. Epub 2022 Feb 13.
6
Cardiogeriatrics: the current state of the art.
Heart. 2024 Jun 25;110(14):933-939. doi: 10.1136/heartjnl-2022-322117.
7
Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association.
Circulation. 2023 Jan 17;147(3):e32-e62. doi: 10.1161/CIR.0000000000001112. Epub 2022 Dec 12.
8
Multimorbidity in Older Adults with Aortic Stenosis.
Clin Geriatr Med. 2016 May;32(2):305-14. doi: 10.1016/j.cger.2016.01.006. Epub 2016 Feb 12.
9
Pathophysiology and Management of Heart Failure in the Elderly.
Int J Angiol. 2022 Nov 11;31(4):251-259. doi: 10.1055/s-0042-1758357. eCollection 2022 Dec.
10
Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults.
Heart Fail Clin. 2017 Jul;13(3):417-426. doi: 10.1016/j.hfc.2017.02.001.

引用本文的文献

1
Gait abnormalities in older adults with transthyretin cardiac amyloidosis.
Amyloid. 2024 Jun;31(2):116-123. doi: 10.1080/13506129.2024.2319133. Epub 2024 Mar 3.
2
Fluvastatin inhibits cardiomyocyte apoptosis after myocardial infarction through Toll pathway.
Exp Ther Med. 2018 Aug;16(2):1350-1354. doi: 10.3892/etm.2018.6297. Epub 2018 Jun 13.
4
5
Off-pump coronary artery bypass grafting in octogenarians.
J Thorac Dis. 2016 Nov;8(Suppl 10):S799-S807. doi: 10.21037/jtd.2016.10.106.
6
The senescence accelerated mouse prone 8 (SAMP8): A novel murine model for cardiac aging.
Ageing Res Rev. 2017 May;35:291-296. doi: 10.1016/j.arr.2016.10.006. Epub 2016 Nov 5.
7
Sarcopenia in heart failure: mechanisms and therapeutic strategies.
J Geriatr Cardiol. 2016 Jul;13(7):615-24. doi: 10.11909/j.issn.1671-5411.2016.07.004.
8
Geriatric cardiology and the Great Wall International Congress of Cardiology 2015.
J Geriatr Cardiol. 2016 May;13(4):279-81. doi: 10.11909/j.issn.1671-5411.2016.04.013.

本文引用的文献

1
What to Expect From the Evolving Field of Geriatric Cardiology.
J Am Coll Cardiol. 2015 Sep 15;66(11):1286-1299. doi: 10.1016/j.jacc.2015.07.048.
2
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.
3
Older Adults' Recognition of Trade-Offs in Healthcare Decision-Making.
J Am Geriatr Soc. 2015 Aug;63(8):1658-62. doi: 10.1111/jgs.13534. Epub 2015 Jul 14.
4
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.
Am J Med. 2015 Dec;128(12):1275-80. doi: 10.1016/j.amjmed.2015.05.039. Epub 2015 Jun 17.
7
Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.
Circ Heart Fail. 2015 May;8(3):519-26. doi: 10.1161/CIRCHEARTFAILURE.113.000890. Epub 2015 Apr 14.
10
Cardiac amyloidosis: the great pretender.
Heart Fail Rev. 2015 Mar;20(2):117-24. doi: 10.1007/s10741-015-9480-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验